There are discrepancies between the recommendations for the management of cardiovascular risk factors and their implementation in clinical practice. In the latest issue of Deutsches Arzteblatt International, Christof Prugger and his fellow authors present the results of the EUROASPIRE I, II and III surveys in the Munster region of Germany (Dtsch Arztebl Int 2012; 109(17): 303). The three surveys, conducted in 1995/96, 1999/2000 und 2006/07 respectively, permitted the authors to trace trends in cardiovascular risk factors over a 12-year period in previously hospitalized patients with coronary heart disease. All patients were aged 70 or younger and their coronary events had occurred at least 6 months before the respective survey. Although it has long been known that giving up smoking leads to a considerable reduction in the risk of cardiovascular morbidity and mortality, the prevalence of smoking remained unchanged. In contrast, the numbers of patients with high blood pressure and high cholesterol went down. The percentage of obese patients almost doubled between 1995 and 2007. The number of patients taking medications to lower their blood pressure and/or cholesterol level increased, as did the number of diabetics. The results of the EUROASPIRE I, II and III surveys in the Münster region show that the targets laid out in the European guidelines have not been achieved in clinical practice.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor